Table 4 Crude and adjusted B-value with 95% CI for change in Patient Specific Functional Scale (PSFS) (− 10 to 10, higher is better) from baseline to 3 months, goal classes, demographical, anthropometric, psychosocial and disease-specific variables. B > 0 indicates better outcome. N = 975
Variable | Univariate regression B (95% CI) | p | Multiple regression model B (95% CI) | p |
|---|---|---|---|---|
Goal classes | ||||
Symptom only | Reference | Reference | ||
Function/structure included | .44 (−.12 to .99) | .126 | .35 (−.25 to .96) | .249 |
Activity/participation included | .52 (.02 to 1.05) | .057 | .16 (−.42 to .74) | 589 |
Non-classifiable | −.51 (−1.31 to .30) | .220 | −.30 (− 1.17 to .56) | .492 |
Age | −.02 (−.03 to .01) | <.001 | −.03 (−.04 to −.02) | <.001 |
Gender | .64 (.23 to 1.05) | .002 | .42 (−.02 to .86) | .061 |
BMI | −.01 (−.03 to.02) | .662 | ||
Treatment beliefa | ||||
Totally agree | Reference | Reference | ||
Agree | −.54 (−.99 to −.08) | .021 | −.37 (−.80 to −.05) | .082 |
Neither agree nor disagree | −1.22 (−2.10 to −.34) | .006 | − 1.10 (− 1.90 to −.30) | .007 |
Emotional distress (HSCL10, score 1–4), | −.87 (− 1.28 to −.47) | <.001 | − 1.39 (− 1.81 to −.97) | <.001 |
Severity (score 0–10) | .52 (.41 to.64) | <.001 | .66 (.53 to .78) | <.001 |
Duration | ||||
< 3 m | Reference | |||
3-12 m | .19 (−.63 to 1.02) | .650 | ||
> 12 m | .44 (−.30 to 1.17) | .246 | ||
Body region/diagnosis | ||||
Spinal | Reference | |||
Upper extremities | .82 (.28 to 1.37) | .003 | ||
Lower extremities | .45 (.01 to .90) | .048 | ||
Unspecific/multisite conditions | −.44 (− 1.16 to .29) | .236 |